Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Early gonadectomies linked with Cranial Cruciate Ligament Disease
Researchers say that removal of gonadal hormones should be performed after musculoskeletal maturity, if at all.
Dogs undergoing an early gonadectomy had a higher risk of CrCLD.

A study has connected early gonadectomy procedures with an increased chance of Cranial Cruciate Ligament Disease (CrCLD) in male and female dogs.

Analysis has suggested that a gonadectomy before 2.9 years in female dogs and 2.2 years in male dogs substantially increased their risk.

The research analyses data from over 20,000 dogs, spanning a range of 36 years. It examined the link between cumulative gonadal hormone exposure and the risk of CrCLD in dogs.

Instead of categorising dogs with arbitrary age categories, the analyst treated gonadal hormone exposure as a continuous variable.

The study revealed the prevalence of CrCLD as 2.49 per cent in females and 1.89 per cent in male dogs.

The risk of CrCLD was found to be higher in dogs which had the least gonadal hormone exposure. This was at 1054 days for female dogs and 805 days for male dogs, with the minimum risk at approximately 2.9 years for females and 2.2 years for males.

Researchers state that the gonadectomy is highly likely to be linked with an increased risk of CrCLD. This suggests that the original suggested cutoff of two years of age is not scientifically grounded.

Based on these findings, the study concludes that removal of gonadal hormones should only be performed after musculoskeletal maturity, if at all.

Dr Daniel Low, lead author of the study, said: “There is an increasing body of evidence associating the development of CrCLD with neutering in both male and female dogs, and that the timing of neutering matters. However, we should not overlook the health benefits of neutering in reducing the risk of other diseases.

“In today’s day and age, practice neutering policies may no longer be appropriate and every decision to neuter is a clinical decision made by the attending veterinary surgeon after consultation with the animal owner”.

The full study can be found in the Journal of Small Animal Practice.

Image © Shutterstock.com/Krakenimages.com

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.